We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Listing

News List

Pharmaceutical News of the Week （June.15th-19th）| PharmaSources.com PharmaSources/Caicai
June 23, 2020
With the third week of June coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 15-19.
Huakang Biomed declares first annual results since listing biospectrumasia
March 26, 2019
Loss Reduced, profit before tax excluding listing expenses amounted to RMB9.1 Million; continuous focus on research and development; lying strong foundation for future growth
Pharmaceutical Enterprises to be Listed in China in 2018 Caicai
May 09, 2018
Let me tell you something horrible today: please see the “progress bar” of 2018 which is about to reach 1/3.
EMA accepts marketing authorization applications for Mylan and Biocon’s proposed biosimilars biospectrumasia
December 04, 2017
European Medicines Agency (EMA) has accepted for review Mylan's Marketing Authorization Applications for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim

Previous page 1 2 Next page